Cargando…
A Case of Fulminant Meningococcemia: It Is All in the Complement
Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541820/ https://www.ncbi.nlm.nih.gov/pubmed/28808592 http://dx.doi.org/10.1155/2017/6093695 |
_version_ | 1783254884745740288 |
---|---|
author | Hawkins, Kellie L. Hoffman, Mariah Okuyama, Sonia Rowan, Sarah E. |
author_facet | Hawkins, Kellie L. Hoffman, Mariah Okuyama, Sonia Rowan, Sarah E. |
author_sort | Hawkins, Kellie L. |
collection | PubMed |
description | Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who presented with a life-threatening case of nongroupable meningococcemia. As this new biologic agent becomes more widely prescribed, providers should be aware of the increased risk of meningococcemia. In addition to vaccination, providers may consider the use of oral penicillin for antibiotic prophylaxis against Neisseria meningitidis in these cases of functional complement deficiency. |
format | Online Article Text |
id | pubmed-5541820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-55418202017-08-14 A Case of Fulminant Meningococcemia: It Is All in the Complement Hawkins, Kellie L. Hoffman, Mariah Okuyama, Sonia Rowan, Sarah E. Case Rep Infect Dis Case Report Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who presented with a life-threatening case of nongroupable meningococcemia. As this new biologic agent becomes more widely prescribed, providers should be aware of the increased risk of meningococcemia. In addition to vaccination, providers may consider the use of oral penicillin for antibiotic prophylaxis against Neisseria meningitidis in these cases of functional complement deficiency. Hindawi 2017 2017-07-20 /pmc/articles/PMC5541820/ /pubmed/28808592 http://dx.doi.org/10.1155/2017/6093695 Text en Copyright © 2017 Kellie L. Hawkins et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Hawkins, Kellie L. Hoffman, Mariah Okuyama, Sonia Rowan, Sarah E. A Case of Fulminant Meningococcemia: It Is All in the Complement |
title | A Case of Fulminant Meningococcemia: It Is All in the Complement |
title_full | A Case of Fulminant Meningococcemia: It Is All in the Complement |
title_fullStr | A Case of Fulminant Meningococcemia: It Is All in the Complement |
title_full_unstemmed | A Case of Fulminant Meningococcemia: It Is All in the Complement |
title_short | A Case of Fulminant Meningococcemia: It Is All in the Complement |
title_sort | case of fulminant meningococcemia: it is all in the complement |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541820/ https://www.ncbi.nlm.nih.gov/pubmed/28808592 http://dx.doi.org/10.1155/2017/6093695 |
work_keys_str_mv | AT hawkinskelliel acaseoffulminantmeningococcemiaitisallinthecomplement AT hoffmanmariah acaseoffulminantmeningococcemiaitisallinthecomplement AT okuyamasonia acaseoffulminantmeningococcemiaitisallinthecomplement AT rowansarahe acaseoffulminantmeningococcemiaitisallinthecomplement AT hawkinskelliel caseoffulminantmeningococcemiaitisallinthecomplement AT hoffmanmariah caseoffulminantmeningococcemiaitisallinthecomplement AT okuyamasonia caseoffulminantmeningococcemiaitisallinthecomplement AT rowansarahe caseoffulminantmeningococcemiaitisallinthecomplement |